◄ back to all posts
Financial data and stock pages provided by
Fintel.io
LCI: Lannett Co., Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 367.13 |
| Enterprise Value ($M) | 981.67 |
| Book Value ($M) | 318.10 |
| Book Value / Share | 7.89 |
| Price / Book | 1.14 |
| NCAV ($M) | -418.76 |
| NCAV / Share | -10.38 |
| Price / NCAV | -0.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.60 |
| Current Ratio | 2.43 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 435.07 |
| Assets | 1,171.93 |
| Liabilities | 853.83 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -262.32 |
| Net Income | -272.11 |
| Earnings Per Share Diluted | -7.20 |
| Earnings Per Share Basic | -7.20 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 176.31 |
| Cash from Investing | -7.29 |
| Cash from Financing | -7.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | D. E. Shaw & Co, L.p. | 8.50 | 1.09 | |
| 13G | Vanguard Group Inc | 5.85 | 172.86 | |
| 13G | Lsv Asset Management | 5.21 | 0.32 | |
| 13G/A | BlackRock Inc. | 13.00 | 9.69 | |
| 13G | JP Morgan Chase & Co | 6.80 | ||
| 13G/A | Mintbroker International, Ltd. | 0.00 | -100.00 | |
| 13G/A | Flynn James E | 0.00 | -100.00 | |
| 13G/A | Snow Capital Management Lp | 0.90 | -87.92 | |
| 13G/A | Invesco Ltd. | 2.10 | -59.22 | |
| 13G | Ucb S.a. | 6.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| LCI / Lannett Co., Inc. 10-Q – Quarterly Report – 10-Q | ||
| LCI / Lannett Co., Inc. 10-Q – Quarterly Report – 10-Q | ||
| LCI / Lannett Co., Inc. 10-K – Annual Report – 10-K | ||
| LCI / Lannett Co., Inc. 10-Q Quarterly Report 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 83,846 | 432,700 | 19.38 | |
| 103,900 | 524,000 | 19.83 | |
| 99,482 | 558,600 | 17.81 | |
| 142,853 | 634,100 | 22.53 | |
| 123,556 | 627,100 | 19.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EBS – Emergent Biosolutions, Inc. | HSP – Hospira |
| JNJ – Johnson & Johnson | LLY – Eli Lilly & Co. |
| MNK – Maillinckrodt plc. |
Financial data and stock pages provided by
Fintel.io
